Biotinylated Human GUCY2C/Guanylyl cyclase C Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02091P-100UG
Biotinylated Human GUCY2C on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human GUCY2C/Guanylyl cyclase C Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02091P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human GUCY2C/Guanylyl cyclase C Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Ser24-Gln430. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P25092 |
Target Symbol | GUCY2C/Guanylyl cyclase C |
Synonyms | Guanylyl cyclase C; GC-C; STAR; GUCY2C; GUC2C; STA receptor; DIAR6; EC 4.6.1; GCC; GUC2CEC 4.6.1.2; MUCIL |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Ser24-Gln430 |
Mol. Weight | The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Anti-GUCY2C Antibody at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human GUCY2C, His Tag with the EC50 of 40.9ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy. |